Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07687537

Cleft Lip and Palate Treatment Outcomes Study

Infants with cleft lip and palate often benefit from presurgical infant orthopedic treatment before surgical repair. Multiple standard of care approaches are selected based on each infant's clinical presentation and family circumstances. This prospective observational cohort study will evaluate clinical outcomes, treatment efficiency, and family burden using routinely collected clinical records and photographs to support individualized, evidence-based PSIO treatment planning.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Presurgical infant orthopedic (PSIO) treatment is widely used to improve alveolar alignment, nasal symmetry, and soft tissue relationships before primary repair in infants with cleft lip and palate. Standard of care approaches include lip taping, nasoalveolar molding (NAM), and other prefabricated systems. Treatment selection is individualized according to each infant's clinical presentation and family circumstances rather than randomly assigned.

Although PSIO is widely practiced, limited prospective evidence compares the clinical outcomes of individualized standard of care treatment approaches in real-world clinical practice. This prospective observational cohort study will evaluate the clinical outcomes of individualized PSIO treatment provided as part of routine clinical care at the University of Florida College of Dentistry. Infants with cleft lip and palate will be prospectively enrolled and will receive lip taping, NAM, or prefabricated appliance, or no presurgical intervention according to clinical indications and family-specific factors. No investigational drugs, investigational devices, or research-only procedures will be used. Clinical outcomes, including alveolar alignment, cleft gap reduction, nasal symmetry, treatment efficiency, and family treatment burden, will be assessed using routinely collected clinical records, photographs, and treatment data. The findings will provide evidence to support individualized, evidence-based treatment planning for PSIO care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of cleft lip and or palate with clinical indication for presurgical infant orthopedic treatment
  • Age appropriate for presurgical infant orthopedic treatment, generally from birth until surgical repair
  • Parent or guardian ability to provide consent
  • Willingness to comply with follow up visits to the extent feasible given family circumstances

Exclusion criteria

  • Other craniofacial syndromes requiring a substantially different management protocol
  • Anticipated inability to complete any follow up
  • Lack of parental consent

Treatment and study plan

Primary outcomes

  1. Change in alveolar segment alignment

    Time frame: Baseline, at each routine follow-up visit during PSIO treatment, and immediately before primary lip repair (approximately 3-5 months).

    Measured on standardized dental model or directly in the mouth using linear measurements (mm).

  2. Change in nasal symmetry

    Time frame: Baseline, at each routine follow-up visit during PSIO treatment, and immediately before primary lip repair (approximately 3-5 months).

    Measured from standardized frontal and basal clinical photographs using anthropometric analysis.

  3. Treatment completion

    Time frame: At primary lip repair (approximately 3-5 months after initiation of PSIO).

    Percentage of participants completing individualized PSIO treatment before primary lip repair.

Secondary outcomes

  1. Number of clinic visits during PSIO treatment

    Time frame: From initiation of PSIO treatment to primary lip repair (approximately 3-5 months)

    Total number of scheduled clinical visits required from initiation of PSIO treatment to primary lip repair.

  2. Duration of PSIO treatment

    Time frame: From initiation of PSIO treatment to primary lip repair (approximately 3-5 months)

    Number of days from initiation of PSIO treatment until primary lip repair.

  3. Number of appliance modifications

    Time frame: From initiation of PSIO treatment to primary lip repair (approximately 3-5 months)

    Total number of appliance adjustments with any issues or remakes required during PSIO treatment.

  4. Caregiver compliance

    Time frame: Initial visiting date to primary lip repair (approximately 3-5 months)

    Percentage of scheduled appointments attended and adherence to prescribed appliance wear documented in clinical records.

  5. Number of treatment-related adverse events

    Time frame: From initiation of PSIO treatment to primary lip repair (approximately 3-5 months)

    Number of participants experiencing treatment-related adverse events, including appliance-related complications, oral mucosal irritation, and unplanned appliance modifications.

Study contacts

Contact information is provided by the study sponsor or research team.

Marcio Guelmann, DDS

CONTACT

[email protected]

352-273-7635

Mi Sook Lee, DMD, MSD, PhD

CONTACT

[email protected]

352-273-7631

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Registry information

Official study title

Outcomes of Individualized Presurgical Infant Orthopedic Treatment Approaches in Infants With Cleft Lip and Palate

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Jul 7, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.